2014 Hyundai Elantra Gt Base on 2040-cars

Auto blog

Hyundai plant one of 100 factories shutting down in wake of Beijing pollution scare

Many factories and chemical plants have suspended production in Beijing in an attempt to curb dangerous pollution, according to the South China Morning Post. The air pollution is some of the worst the city has seen in years, with harmful PM2.5 particle rates hovering between 200 and 400 micrograms per cubic meter. That number is down from as high as 886 on Sunday. For contrast, the US Environmental Protection Agency regulations say PM2.5 concentration at any location be no higher than 65 micrograms per cubic meter, with average maximums not to exceed 15 micrograms per cubic meter.
China blames the pollution on vehicle emissions, industrial production and an increase in domestic coal use to heat homes during cold weather. A total of 48 work sites, including construction zones, metal refineries and chemical plants have suspended production, and 41 factories have cut back production as well. That includes Hyundai Motor Beijing, which suspended production on Sunday.
Even so, the area's children's hospitals are receiving up to 10,000 patients per day with respiratory ailments. The city's government says it is in the midst of an eight-year plan to curb pollution and that levels have dropped between 30 and 70 percent over the past 14 years thanks to its actions.

Hyundai’s N division will tune electrics, steer clear of Genesis

At Hyundai's Namyang proving ground in a small garage emblazoned with a giant "N," Albert Biermann, the ex-BMW engineer who now heads up vehicle development for the Korean brand, recently provided a few hints about what to expect from Hyundai's nascent performance sub-brand — and that includes EVs. "We are looking for the right ideas of how to transfer the craziness of N into electrification," he said. That could be "a full EV [and] also could be a hybrid." To date, we've seen the Veloster N introduced last fall in the United States, followed by the recently announced Elantra GT N Line. Europe has the i30 N in hatchback and fastback body styles. Biermann says, "We will expand also into segments we are not in now," including "something a little bit smaller," as well as into "a different type of vehicle." Biermann also said we can expect a more powerful version of the new 2020 Hyundai Sonata — which we've just reviewed, and which will launch in the United States with a 180-hp 1.6-liter turbo and a 191-hp 2.5-liter naturally aspirated four. But he stopped short of saying whether it would be an N or an N Line model. And it appears that the N expansion will not extend to Genesis. "There are no plans yet to make a sub-label for Genesis like we did with N for Hyundai," Biermann said. This despite the fact that nearly all of its rivals have branched out in that direction. For now, it seems, the G70 Sport is as sporty as it will get over at Genesis.

Hyundai tops Toyota in annual CarMD Vehicle Health Index

CarMD has released its third annual Vehicle Health Index, which for the 2013 tracked the frequency and cost of repairs for "check engine" problems of 119-million vehicles built between the 2003 and 2013 model years. For the first two years of the index, Toyota ranked at the top of the list, but this year's results see Hyundai moved to number one, pushing Toyota down a spot.
The Korean automaker's rise to the top has been "fueled by its low repair frequency," according to CarMD. Toyota is second to Hyundai in lowest repair frequency, but Toyotas also have the highest average cost of repair. (Interestingly, General Motors vehicles have the lowest average.) Both Toyota's and Hyundai's manufacturer "health" ratings suffered this year, but Toyota took a bigger hit, which also is what helped Hyundai achieve the top ranking.
While Hyundai is the top manufacturer in the index, the 2012 Toyota Camry is the top vehicle. The best-ranking Hyundai was the 2010 Elantra (behind three Nissan models and four Toyotas), which took the number eight spot. Hyundai has six other vehicles in the top 100.